Neurofibromin as a regulator of melanocyte development and differentiation

Journal of Cell Science

Volumn 121, Issue 2, 2008, Pages 167-177

  Diwakar, Ganesh ^a   Zhang, Deming ^a   Jiang, Shunlin ^a   Hornyak, Thomas J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Development; Melanocyte; Neurofibromin

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; NEUROFIBROMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; ENZYME ACTIVATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE EXPRESSION REGULATION; GROWTH REGULATION; MELANOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WILD TYPE;

ALLELES; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HETEROZYGOTE; MAP KINASE SIGNALING SYSTEM; MELANOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NEUROFIBROMIN 1;

MURINAE; MUS;

EID: 38949216683     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.013912     Document Type: Article

References (59)

1. Abdel-Malek, Z. A., Scott, M. C., Furumura, M., Lamoreux, M. L., Ollmann, M., Barsh, G. S. and Hearing, V. J. (2001). The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes. J. Cell Sci. 114, 1019-1024.
2. Bader, J. L. and Miller, R. W. (1978). Neurofibromatosis and childhood leukemia. J. Pediatr. 92, 925-929.
3. Ballester, R., Marchuk, D., Boguski, M. Saulino, A., Letcher, R., Wigler, M. and Collins, F. (1990). The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63, 851-859.
4. Bennett, D. C., Cooper, P. J. and Hart, I. R. (1987). A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int. J. Cancer 39, 414-418.
5. Boling, G., Clapp, D. W., Shih, S., Adler, F., Zhang, Y., Thompson, P., Lange, B. J., Freedmam, M. H., McCormick, F., Jacks, T. et al. (1996). Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in murine and human hematopoietic cells. Nat. Genet. 12, 144-148.
6. +/-) melanocytes reveals downregulation of a transcriptional cis-regulatory network mediating activation of the melanocyte-specific dopachrome tautomerase (DCT) gene. Pigment Cell Res. 18, 285-299.
7. Brannan, C. I., Perkins, A. S., Vogel, K. S., Ratner, N., Nordlund, M. L. Reid, S. W., Buchberg, A. M., Jenkins, N. A., Purads, L. F. and Copeland, N. G. (1994). Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev. 8, 1019-1029.
8. Colman, S. D., Williams, C. A. and Wallace, M. R. (1995). Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat. Genet. 11, 90-92.
9. Davies, S. P., Reddy, H., Caivano, M. and Cohen, P. (2000). Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105.
10. DeClue, J. E., Papageorge, A. G., Fletcher, J. A., Diehl, S. R., Ratner, N., Vass, W. C. and Lowy, D. R. (1992). Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69, 265-273.
11. Eisenbarth, I., Assum, G., Kaufmann, D. and Krone, W. (1997). Evidence for the presence of the second allele of the Neurofibromatosis Type 1 gene in melanocytes derived from café au lait macules of NF1 patients. Biochem. Biophys. Res. Commun. 237, 138-141.
12. Englaro, W., Bertolotto, C., Busca, R., Brunet, A. Pages, G., Ortonne, J. P. and Ballotti, R. (1998). Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation. J. Biol. Chem. 273, 9966-9970.
13. Esterly, N. B. Baselga, E., Drolet, B. A. and Bridges, A. G. (1998). Neurofibromatosis. In The Pigmentary System: Physiology and Pathophysiology (ed. J. J. Nordlund, R. E. Boissy, V. J. Hearing, R. A. King and J.-P. Ortonne), pp. 741-747. New York: Oxford University Press.
14. Glover, T. W., Stein, C. K., Legius, E., Andersen, L. B., Brereton, A. and Johnson, S. (1991). Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis. Genes Chromosomes Cancer 3, 62-70.
15. Gray-Schopfer, V. C., Cheong, S. C., Chong, H., Chow, J., Moss, T., Abdel-Malek, Z. A., Marais, R., Wynford-Thomas, D. and Bennett, D. C. (2006). Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br. J. Cancer 95, 496-505.
16. Griesser, J., Kaufmann, D., Eisenbarth, I., Baeuerle, C. and Krone, W. (1995). Ras-GTP regulation is not altered in cultured melanocytes with reduced level of neurofibromin derived from patients with neurofibromatosis 1 (NF1). Biol. Chem. Hoppe-Seyler 376, 91-101.
17. Gutmann, D. H., Aylsworth, A., Carey, J. C., Korf, B., Marks, J., Pyeritz, R. E., Rubenstein, A. and Viskochil, D. (1997). The diagnostic evaluation and multidisciplinary management of neurofibromatosts 1 and neurofibromatosis 2. JAMA 278, 51-57.
18. Halaban, R. and Alfano, F. D. (1984). Selective elimination of fibroblasts from cultures of normal human melanocytes. In Vitro 20, 447-450.
19. Hemesath, T. J., Price, E. R., Takemoto, C., Badalian, T. and Fisher, D. E. (1998). MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature 391, 298-301.
20. Hodgkinson, C. A., Moore, K. J., Nakayama, A., Steingrímsson, E., Copeland, N. G., Jenkins, N. A. and Arnheiter, H. (1993). Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74, 395-404.
21. Hornyak, T. J., Hayes, D. H., Chiu, L.-Y. and Ziff, E. B. (2001). Transcription factors in melanocyte development: distinct roles for Pax-3 and Mitf. Mech. Dev. 101, 47-59.
22. Hou, L., Panthier, J. J. and Arnheiter, H. (2000). Signaling and transcriptional regulation in the neural crest-derived melanocyte lineage: interactions between KIT and MITF. Development 127, 5379-5389.
23. Ingram, D. A., Yang, F. C., Travers, J. B., Wenning, M. J., Hiatt, K., New, S., Hood, A., Shannon, K., Williams, D. A. and Clapp, D. W. (2000). Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J. Exp. Med. 191, 181-188.
24. Jacks, T., Shih, T. S., Schmitt, E. M., Bronson, R. T., Bernards, A. and Weinberg, R. A. (1994). Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat. Genet. 7, 353-361.
25. Johnson, M. R., Look, A. T., DeClue, J. E., Valentine, M. B. and Lowy, D. R. (1993). Inactivation of the NF1 gene in burnan melanoma and neuroblast cell lines without impaired regulation of GTPRas. Proc. Natl. Acad. USA 90, 5539-5543.
26. Johnson, M. R., DeClue, J. E., Felzmann, S., Vass, W. C., Xu, G., White, R. and Lowy, D. R. (1994). Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Mol. Cell. Biol. 14, 641-645.
27. Kauftnann, D., Wiandt, S., Veser, J. and Krone, W. (1991). Increased melanogenesis in cultured epidermal melanocytes from patients with neurofibromatosts 1 (NF 1). Hum. Genet. 87, 144-150.
28. Kint, D. K., Morli, E., Ogihara, H., Lee, Y. M., Jippo, T., Adachi, S., Maeyama, K., Kim, H. M. and Kitamura, Y. (1999). Different effect of various mutant MITF encoded by mi, Mior, or Miwh allele on phenotype of murine most cells. Blood 93, 4179-4186.
29. Korf, B. R. (2000). Malignancy in neurofibromatosis type 1. Oncologist 5, 477-485.
30. Kunisada, T., Yoshida, H., Ogawa, M., Shultz, L. D., and Nishikawa, S.-I. (1996). Characterization and isolation of melanocyte progenitors embryos. Dev. Growth Differ. 38, 87-97.
31. Loaning, J. L., Wallace, J. S., Zhang, D., Diwakar, G., Jiao, Z. and Hornyak, T. J. (2005). Altered melanocyte differentiation and retinal pigmented epithelium transdifferentiation induced by Mash1 expression in pigment cell precursors. J. Invest. Dermatol. 125, 805-817.
32. Livak, K. J. and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.
33. Marshall, C. J. (1995). Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-195.
34. McGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y. L., Ramaswamy, S., Avery, W., Ding, H. F. et al. (2002). Bc12 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109, 707-718.
35. Menon, A. G., Anderson, K. M., Riccardi, V. M., Chung, R. Y., Whaley, J. M., Yandell, D. W., Former, G. E., Freiman, R. N., Lee, J. K., Li, F. P. et al. (1990). Chromosome 17p deletions and p53 gone mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc. Natl. Acad. Sci. USA 87, 5435-5439.
36. Michaloglou, C., Vredeveld, L. C., Soengas, M. S, Denoyelle, C., Kuilman, T., van der Horst, C. M., Majoor, D. M., Shay, J. W., Mooi, W. J. and Peeper, D.S. (2005). BRAFE600-associated senescence-like cell cycle arrest of human naevin. Nature 436, 720-724.
37. Nishimura, E. K., Granter, S. R. and Fisher, D. E. (2005). Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science 307, 720-724.
38. 41 and W. EMBO J. 9, 1805-1813.
39. Okazaki, M., Yoshimura, K., Suzuki, Y., Uchida, G., Kitano, Y., Harii, K. and Imokawa, G. (2003). The mechanism of epidermal hyperpigmentation i case-au-lait macules of neurofibromatosis type 1 (von Recklinghausen's disease) may be associated with dermal fibroblast-derived stem cell factor and hepatocyte growth factor. Br. J. Dermortol. 148, 689-697.
40. Opdecamp, K., Nakayama, A., Nguyen, M.-T. T., Hodgkinson, C. A, Pavan, W. J. and Arnheiter, H. (1997). Melanocyte development in vivo and in neural crest cell cultures: crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription factor. Development 124, 2377-2386.
41. Riccardi, V. M. (1992). Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. Baltimore: The Johns Hopkins University Press.
42. Sawada, S., Florell, S., Purandare, S. M., Ota, M., Stephens, K. and Viskochil, D. (1996). Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nat. Genet. 14, 110-112.
43. Serra, E., Puig, S., Otero, D., Gaona, A., Kruyer, H., Ars, E., Estivill, X. and Lazaro, C. (1997). Confirmation of a double-hit model for the NF1 gin benign neurofibromas. Am. J. Hum. Genet. 61, 512-519.
44. Skuse, G. R., Kosciolek, B. A. and Rowley, P. T. (1989). Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: loss of heterozygosity for chromosome 17. Genes Chromosomes Cancer 1, 36-41.
45. Stiller, C. A., Chessells, J. M. and Fitchett, M. (1994). Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCG study. Br. J. Cancer 70, 969-972.
46. Suzuki, H., Takahashi, K., Yasumoto, K. and Shibahara, S. (1994). Activation of the tyrosinase gene promoter by neurofibromin. Biochem. Biophys. Res. Commun. 205, 1984-1991.
47. Suzuki, H., Takahashi, K., Yasumoto, K., Amae, S. Yoshizawa, M., Fuse N. and Shibahara, S. (1998). Role of neurofibromin in modulation of expression of the tyrosinase-related protein 2 gene. J. Biochem. 124, 992-998.
48. Sviderskaya, E. V., Hill, S. P., Evans-Whipp, T. J., Chin, L., Orlow, S. J., Easty, D. J., Cheong, S. C., Reach, D., DePinho, R. A. and Bennett, D. C. (2002). p16(Ink4a) in melanocyte senescence and differentiation. J. Natl. Cancer Inst. 94, 446-454.
49. Theos, A. and Korf, B. R. (2006). Pathophysiology of neurofibromatosis type 1. Ann. Intern. Med. 144, 842-849.
50. Tsujimura, T., Morii, E., Nozaki, M., Hashimoto, K., Moriyama, Y., Takehayashi, K., Kondo, T., Kanakura, Y. and Kitamura, Y. (1996). Involvement of transcription factor encoded by the mi locus in the expression of c-kit receptor tyrosine kinase in cultured mast cells of mice. Blood 88, 1225-1233.
51. Tsukamoto, K., Jackson, I. J., Urabe, K., Montague, P. M. and Hearing, V. J. (1992). A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J. 11, 519-526.
52. Urzua, U., Roby, K. F., Gangi, L. M., Cherry, J. M., Powell, J. I. and Munroe, D. J. (2006). Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: functional similarity to the human disease and identification of prospective tumoral markers and targets. J. Cell. Physiol. 206, 594-602.
53. Wang, D. and Richmond, A. (2001) Nuclear factor-kappa B activation by the CXC chemokine melanoma growth-stimulatory activity/ growth-regulated protein involves the MEKK1/p38 mitogen-activated protein kinase pathway. J. Biol. Chem. 276, 3650-3659.
54. Walker, G. J., Flores, J. F., Glendening, J. M., Lin, A. H., Markl, I. D. and Fountain, J. W. (1998). Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets. Genes Chromosomes Cancer 22, 157-163.
55. Wehrle-Haller, B, Meller, M. and Weston, J. A. (2001). Analysis of melanocyte precursors in Nf1 mutants reveals that MGF/KIT signaling promotes directed cell migration independent of its function in cell survival. Dev. Biol. 232, 471-483.
56. Win, M., Hemesath, T. J., Takemoto, C. M., Horstmann, M. A., Wells, A. G, Price, E. R., Fisher, D. Z. and Fisher, D. E. (2000). c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev. 14, 301-312.
57. Xu, W., Mulligan, L. M., Ponder, M. A., Liu, L., Smith, B. A., Mathew, C. G. and Ponder, B. A. (1992). Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis. Genes Chromosomes Cancer 4, 337-342.
58. +/- mast cells. J. Clin. Invest. 112, 1851-1861.
59. Zhang, Y. Y., Vik, T. A., Ryder, J. W., Srour, E. F., Jacks, T., Shannon, K. and Clapp, D. W. (1998). Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines. J. Exp. Med. 187, 1893-1902.